Company Encyclopedia
View More
name
Retractable Tech
RVP.US
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network.
330.79 B
RVP.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Health Care SuppliesIndustry
Industry Ranking39/42
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-8.36%D
    • Profit Margin-17.01%D
    • Gross Margin16.72%D
  • Growth ScoreC
    • Revenue YoY-0.95%D
    • Net Profit YoY58.17%B
    • Total Assets YoY-7.21%D
    • Net Assets YoY-8.00%D
  • Cash ScoreD
    • Cash Flow Margin-567.64%E
    • OCF YoY-0.95%D
  • Operating ScoreD
    • Turnover0.25D
  • Debt ScoreC
    • Gearing Ratio47.57%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Medical device firm Retractable's Q3 sales dip

    Retractable Technologies' Q3 2025 sales slightly declined to $10.1 million from $10.3 million last year. Operating loss reduced to $3.7 million from $5.1 million. The company reported a net income of $371 thousand, aided by $2.4 million unrealized gains. Tariffs continue to impact costs, with $2.3 million spent on tariffs in the first nine months of 2025. International revenues increased by 25% in Q3, but average selling price declined due to product discounts.

    fidelity·
    US
    RVP
    -0.86%
    fidelity·
    US
    RVP
    -0.86%

    Retractable Technologies Reports Q3 Net Sales of $10.1 Million and Net Income of $371 Thousand

    Retractable Technologies Inc. reported Q3 2025 net sales of $10.1 million and net income of $371 thousand. The company had an operating loss of $3.7 million, an improvement from $5.1 million in Q3 2024. For the first nine months of 2025, net sales were $28.8 million with operating losses of $13.5 million. International revenues rose 38.1%, but unit sales decreased 12.4% for the quarter. Operating expenses increased 4.3% due to product donations and higher bad debt expense.

    Reuters·
    US
    RVP
    -0.86%
    Reuters·
    US
    RVP
    -0.86%

    Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle | RVP Stock News

    Retractable Technologies, Inc. announced that its EasyPoint Blood Collection Tube Holder with Needle received an Innovative Technology designation from Vizient, a leading healthcare performance improvement company. This recognition highlights the product's potential to enhance clinical care and safety. The EasyPoint device features automated retraction for safety, efficiency, and reliability, reducing needlestick injuries and improving workflow. CEO Thomas Shaw expressed pride in the acknowledgment, affirming the company's commitment to safety and innovation in healthcare.

    StockTitan·
    US
    RVP
    -0.86%
    StockTitan·
    US
    RVP
    -0.86%

    Retractable Tech | 10-Q: FY2025 Q3 Revenue: USD 10.09 M

    LB filings·
    US
    RVP
    -0.86%
    LB filings·
    US
    RVP
    -0.86%

    Thomas J. Shaw, President and CEO, Acquires Common Shares of Retractable Technologies Inc

    Thomas J. Shaw, President and CEO of Retractable Technologies Inc., has acquired common shares of the company. This event was reported through a filing accessible via the U.S. SEC's EDGAR system. The information is provided by Public Technologies using AI and is for informational purposes only, not as financial advice.

    Reuters·
    US
    RVP
    -0.86%
    Reuters·
    US
    RVP
    -0.86%
    © 2025 Longbridge｜Disclaimer